-+ 0.00%
-+ 0.00%
-+ 0.00%

CytoSorbents Extends Avenue Capital Loan Maturity to July 2028

PUBT·11/20/2026 13:04:28
Listen to the news
CytoSorbents Extends Avenue Capital Loan Maturity to July 2028
  • CytoSorbents amended its Avenue Capital credit facility November 19, 2026, reducing principal by $5.25 million to $12.25 million.
  • The $6.25 million financing comprises a $4 million registered direct offering and a $2.25 million debt-for-equity exchange.
  • Offering proceeds will fund a $3 million principal repayment; Avenue receives 455,465 common shares at $4.94 per share for exchanged debt.
  • Maturity extends one year to July 1, 2028, with interest-only payments extended 15 months through March 31, 2028.
  • The debt reduction is expected to save approximately $700,000 in interest expense over 12 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoSorbents Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611200800PR_NEWS_USPR_____NY03409) on November 20, 2026, and is solely responsible for the information contained therein.